Physician profile
Vincent Bruno
NPI 1134783210
$3,290.71
in general payments reported to CMS, 2019-2025
27 companies · $227 in 2025
The $227 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $714 · 2022: $1,226 · 2023: $746 · 2024: $377 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,350.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $532.45 | 2021-2023 | Delstrigo, Dificid, Pifeltro |
| Abbvie INC. | $472.33 | 2022-2024 | |
| Melinta Therapeutics, LLC | $313.29 | 2021-2024 | Rezzayo |
| Regeneron Healthcare Solutions, INC. | $206.96 | 2022-2025 | Dupixent |
| Glaxosmithkline, LLC. | $203.10 | 2022-2025 | Nucala |
| Viiv Healthcare Company | $174.21 | 2022-2025 | Rukobia, Cabenuva |
| Mylan Specialty L.P. | $160.82 | 2022-2024 | Yupelri |
| Teleflex LLC | $159.51 | 2023 | Arrow |
| Shionogi INC | $142.50 | 2021-2023 | Fetroja |
| Organogenesis INC. | $126.49 | 2021-2022 | |
| Grifols USA, LLC | $101.46 | 2023-2025 | Prolastin-C Liquid |
| Janssen Products, LP | $99.95 | 2021 | |
| Paratek Pharmaceuticals, INC. | $93.70 | 2021-2022 | |
| Janssen Biotech, INC. | $83.50 | 2021-2023 | Symtuza |
| Astellas Pharma US INC | $78.78 | 2022-2023 | Cresemba |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $48.54 | 2021-2023 | |
| Napo Pharmaceuticals INC | $42.96 | 2023-2024 | Mytesi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.45 | 2021-2022 | |
| Tactile Systems Technology INC | $30.17 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $27.86 | 2021 | |
| United Therapeutics Corporation | $25.92 | 2025 | Tyvaso |
| Theratechnologies INC. | $25.61 | 2021 | |
| Inspire Medical Systems, INC. | $22.96 | 2025 | Inspire |
| Insmed, INC. | $22.67 | 2024 | Arikayce |
| Convatec INC. | $22.16 | 2022 | |
| Viatris Specialty LLC | $19.72 | 2025 | Yupelri |
| Pfizer INC. | $14.64 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Bruno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.